4//SEC Filing
Fairman Jeff 4
Accession 0001209191-22-044659
CIK 0001649094other
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 7:12 PM ET
Size
8.3 KB
Accession
0001209191-22-044659
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
Fairman Jeff
VP, Research
Transactions
- Sale
Common Stock
2022-08-04$25.50/sh−10,000$255,000→ 311,227 total(indirect: By Trust) - Sale
Common Stock
2022-08-05$25.70/sh−5,000$128,508→ 306,227 total(indirect: By Trust)
Holdings
- 17,662
Common Stock
- 50,000(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported is a weighted-average price. The shares were sold at prices ranging from $25.50 to $26.035. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Documents
Issuer
Vaxcyte, Inc.
CIK 0001649094
Entity typeother
Related Parties
1- filerCIK 0001813800
Filing Metadata
- Form type
- 4
- Filed
- Aug 4, 8:00 PM ET
- Accepted
- Aug 5, 7:12 PM ET
- Size
- 8.3 KB